Optimizing Postpartum Pelvic Health Through Self-Scar Tissue Massage of Episiotomy and Perineal Scar Tissue A Pilot RCT
EPIS
1 other identifier
interventional
14
1 country
1
Brief Summary
The goal of this Pilot Randomized Control Trial (RCT) is to determine if a larger RCT evaluating the effect of self-scar tissue massage of episiotomy and/or vagina/perineal tear scar tissue on pelvic health outcomes is feasible. The main questions it aims to answer are: Can the investigators recruit 130 participants and aim for 80% retention of participants in this study? Are the response rates to questionnaires and completeness of questionnaires acceptable? Do the participants find the self-scar tissue massage intervention easy and acceptable to perform and do they adhere to the protocol? Type of Study: Clinical Trial Participant Population/Health Conditions: The participant population will be 18 years of age or older, primiparous, within 1 year postpartum after vaginal delivery with healed episiotomy and/or vaginal perineal tear(s) as confirmed to them by their maternity care provider or family doctor at their 6 week postpartum check or other appointment. The participants will also need to have sufficient proficiency in English to understand intervention instructional video and complete written questionnaires. Investigators will compare the scores on two reliable and validated pelvic health questionnaires in those in the intervention and control groups. The intervention group will be provided an instructional video on self-scar tissue massage and asked to perform self-scar massage and record their intervention and experience over a 6-week period. The control group will receive routine postnatal care (no self-scar massage training or performance). Patient medical records will be used to collect demographic data and labour and delivery characteristics. Two reliable and validated pelvic health questionnaires will be used for outcome measures. Baseline outcomes will be performed at the start of the study and then repeated 6 weeks later and again 18 weeks later.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 15, 2023
CompletedFirst Posted
Study publicly available on registry
June 18, 2023
CompletedStudy Start
First participant enrolled
September 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 9, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedMarch 30, 2026
December 1, 2024
1.3 years
May 15, 2023
March 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Rate of Participant Recruitment
To evaluate the rate of participant recruitment, the investigators will calculate how many participants were recruited on average per month per hospital site.
1 year
Rate of Participant Attrition
To evaluate the rate of participant attrition, the investigators will calculate the number of participants that drop out of the study over the total number of participants that are randomized in the study over the study period.
1 year
Number of Pelvic Floor Distress Inventory (PFDI-20) Outcome Measures with missing data
To evaluate the response rate and the completeness of the PFDI-20 the investigators will track how many questionnaires are not completed and determine if there is any missing data in the responses to the PFDI-20.
1 year
Number of The Carol Scale with missing data
To evaluate the response rate and the completeness of the Carol Scale the investigators will track how many questionnaires are not completed and determine if there is any missing data in the responses to the Carol Scale.
1 year
Number of participants to complete self-scar massage protocol as intended
To evaluate the acceptability of the self-scar massage intervention, the investigators will examine participants' reported intervention frequency and time of intervention on their records and note any deviation from the intervention protocol. Some participant interviews will be conducted from a program evaluation lens to determine how the intervention was received. Exemplar quotes will be used to describe participants experience of the self-scar massage intervention.
1 year
Study Arms (2)
Episiotomy and Vaginal/Perineal Tear Self-Scar Massage
EXPERIMENTALThis Arm will be instructed in and perform self-scar massage to their pelvic floor scar tissue.
Standard Postnatal Care
NO INTERVENTIONThis Arm will not be instructed in or perform self-scar massage to their pelvic floor scar tissue.
Interventions
Self scar-massage intervention of healed pelvic floor scar tissue for 5 minutes, 3x/week for 6 weeks.
Eligibility Criteria
You may qualify if:
- Age ≥18 years
- Primiparous
- Within 1 year postpartum after vaginal delivery with episiotomy and/or vaginal/perineal tear
- Healed episiotomy and/or vagina/perineal tear as confirmed to them by their maternity care provider or family doctor at their postpartum check or other appointment
- Sufficient proficiency in English to understand intervention instructional video and complete written questionnaires.
You may not qualify if:
- Self-reported current vaginal infection or urinary tract infection
- Self-reported gynecological surgery after delivery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Calgarylead
- Alberta Health servicescollaborator
- Alberta Innovates Health Solutionscollaborator
Study Sites (1)
University of Calgary
Calgary, Alberta, T2N 1N4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erin Brennand, MD, MSc
University of Calgary
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2023
First Posted
June 18, 2023
Study Start
September 21, 2023
Primary Completion
January 9, 2025
Study Completion
March 1, 2025
Last Updated
March 30, 2026
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share